FindTrial
Sign In

To assess the impact of progressive yogic exercises on changes in skeletal muscle mass, strength and function in obese patients who have loss of both muscle mass and strength

To assess the impact of progressive yogic exercises on changes in skeletal muscle mass, strength and function in obese patients with Dynapenia/Sarcopenia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087684
Enrollment
100
Registered
2025-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E660- Obesity due to excess calories

Interventions

Intervention1: Progressive yogic exercises with Standard Diet: Structured Yogic exercises: The participants in Yogic exercise group will be advised to practice one hour of yogic exercise at least fiv

Sponsors

Department of Science and Technology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: age 20-60 years BMI more than or equal to 25 Appendicular skeletal muscle mass by height2: Men less than 7.0 kg per metre square and Women less than 5.4 kg per metre square Hand grip strength- Men less than 28 kg Women less than 18 kg SPPB less than or equal to 8 (The maximum score on the SPPB is 12)

Exclusion criteria

Exclusion criteria: Known or recently diagnosed diabetes mellitus or coronary heart disease Contraindication to progressive yogic training like severe neurological disorder. Any severe acute or chronic illness, severe end organ dysfunction, post organ transplant Known malignancy, HIV/ HBsAg/Anti HCV positivity Chronic alcohol use (more than 30 g/day in men and more than 20 g/day in women) or any other drug abuse Use of any medications that may affect the muscle function or mass such as corticosteroids, anabolic steroids, protein supplements, performance enhancing medications etc. Pregnancy and lactation, any physical deformity or loss of extremity

Design outcomes

Primary

MeasureTime frame
Muscle strength, skeletal muscle mass and function in obese Dynapenia/sarcopenic individualsTimepoint: Skeletal muscle mass, strength and function in obese Dynapenia/sarcopenic individuals at baseline, 1.5 months and 3 months—

Secondary

MeasureTime frame
Changes in body composition, anthropometric parameters, quality of lifeTimepoint: Changes in body composition, metabolic parameters, insulin resistance, subclinical inflammation, quality of life at baseline, 1.5 months & 3 months—

Countries

India

Contacts

Public ContactDr Naval K Vikram

All India Institute of Medical Sciences, New Delhi

navalvikram@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026